TagsPancreatic

Tag: Pancreatic

Healthcare

Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer

Ravindra Soni - May 20, 2026 0

Healthcare

AnBogen Therapeutics to Present Dual Breakthroughs for Imofinostat (ABT-301) at AACR 2026: Addressing Immunotherapy Barriers in CRC and Chemo-resistance in Pancreatic Cancer

Ravindra Soni - April 13, 2026 0

Healthcare

Continuity Biosciences Acquires Focal Medical to Advance Targeted Drug Delivery for Pancreatic Cancer

Ravindra Soni - June 4, 2025 0

Automobile

Golden Biotech’s Antroquinonol Shows Significantly Prolonged Survival in Untreated Metastatic Pancreatic Cancer Patients

Ravindra Soni - January 18, 2024 0

Most Read

HID joins FIDO Alliance Board, appoints Sean Dyon as Primary Delegate

October 14, 2026

Swan Realty launches Bodhi luxury residential project in Bengaluru’s Jayanagar

October 14, 2026

Tata Elxsi Q2 FY27 revenue rises 15% YoY to Rs 1,055.7 crore

October 14, 2026

CRIF-SIDBI report: Small business credit portfolio hits ₹50.9 lakh crore in June 2026

October 14, 2026

EDITOR PICKS

HID joins FIDO Alliance Board, appoints Sean Dyon as Primary Delegate

October 14, 2026

Swan Realty launches Bodhi luxury residential project in Bengaluru’s Jayanagar

October 14, 2026

Tata Elxsi Q2 FY27 revenue rises 15% YoY to Rs 1,055.7 crore

October 14, 2026

POPULAR POSTS

HID joins FIDO Alliance Board, appoints Sean Dyon as Primary Delegate

October 14, 2026

Swan Realty launches Bodhi luxury residential project in Bengaluru’s Jayanagar

October 14, 2026

Tata Elxsi Q2 FY27 revenue rises 15% YoY to Rs 1,055.7 crore

October 14, 2026

ABOUT US

BusinessFortnight (businessfortnight.com) is an Indian digital news and media platform that covers business, economy, banking, insurance, real estate, automobiles, aviation, and hospitality news

Contact us: editorbusinessfortnight(@)gmail.com

© BusinessFortnight.com. All Rights Reserved.